This pro-inflammatory state can directly promote hepatic inflammation, accelerate the progression from simple steatosis to steatohepatitis (NASH), and thereby worsen hepatocellular injury.[27–29] This pathway may represent a key biological mechanism underlying the association between the ALT/AST ratio and OSA risk. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.